The prodisc portfolio now includes four cervical and two lumbar devices. Five have been approved by the FDA, according to an Oct. 3 news release.
Centinel Spine’s Prodisc C Vivo and C SK cervical disc implants also reached a milestone last month, surpassing 2,500 cases in just one year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
